Infections
Plain language summary: real-world effectiveness of Ceftazidime-Avibactam combination therapy for bacterial diseases
Effectiveness and safety of rezafungin versus caspofungin for candidaemia and invasive candidiasis: plain language summary of the STRIVE and ReSTORE studies
A plain-language summary of two 5-Year studies on bictegravir/emtricitabine/tenofovir alafenamide in people with HIV
A plain language summary looking at isavuconazole to treat mold infections in Asia and the Western Pacific region
Plain Language Summary: the efficacy and safety of bepirovirsen in people with chronic hepatitis B infection
A plain language summary discussing whether the COVID-19 pandemic changed resistance to current antifungal medicines
Plain language summary: A. fumigatus fungi samples that show resistance to antifungal medicines have changes in their genes
A plain language summary of the impact of vaccines against flu and chickenpox in people with multiple sclerosis treated with cladribine tablets
Plain language summary of Pfizer-BioNTech BNT162b2 vaccine protection against COVID-19 and its safety in participants 12- to 15-years-old
Plain language summary of Pfizer-BioNTech BNT162b2 COVID-19 vaccine safety in participants 16 years or older and protection against COVID-19 in participants 12 years or older
Study of an antifungal medicine isavuconazole used in treatment of mold infections in China: A plain language summary
Plain language summary of Pfizer-BioNTech BNT162b2 COVID-19 vaccine safety in participants 16 years or older and protection against COVID-19 in participants 12 years or older
The role of diagnostic tests in antifungal stewardship for treating invasive fungal infections: a plain language summary
A plain language summary of the Janssen COVID-19 vaccine effectiveness and safety as a single dose and with a booster
Risk factors in people with mold infections that have spread to different parts of the body: A plain language summary